Get startedLog in
    Picture of Newbury Pharmaceuticals AB logo

    NEWBRY — Newbury Pharmaceuticals AB News Story

    0.000.00%
    se flag iconLast trade - 00:00
    Consumer DefensivesHighly SpeculativeMicro CapMomentum Trap
    All News

    Brief: Newbury Pharmaceuticals Q2 EBITDA Loss Widens To SEK 3.4 Mln

    Picture of Newbury Pharmaceuticals AB logoNewbury Pharmaceuticals AB
    13/04/2022 07:06
    April 13 (Reuters) - Newbury Pharmaceuticals AB  NEWBRY.ST :
    * NEWBURY PHARMACEUTICALS INTERIM REPORT SEPTEMBER 2021 –
FEBRUARY
2022
    * Q2 NET REVENUE WAS 302 (0) TKR
    * Q2 EBITDA WAS -3 382 (-920) TKR

Source text for Eikon:  ID:nMFN54RYDt 
Further company coverage:  NEWBRY.ST 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

    Recent news on Newbury Pharmaceuticals AB

    See all news